RedHill Biopharma reported $19.22M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Cara Therapeutics USD 11.04M 2K Dec/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
Cronos Group USD 42.42M 5.77M Mar/2026
RedHill Biopharma USD 19.22M 3.07M Dec/2025